PHASE 1 STUDY OF AUTOLOGOUS ACTIVATED T CELLS TRANSDUCED WITH A THIRD-GENERATION GD2 CHIMERIC ANTIGEN RECEPTOR, COEXPRESSION OF IL-15, AND ICASPASE9 SAFETY SWITCH
$799,140FY2020Defense Health AgencyDOD
University Of North Carolina At Chapel Hill, Chapel Hill NC